'Stop Ripping Us Off': Senate Goes After Ozempic-Maker Over Pricing

(MedPage Today) -- Sen. Bernie Sanders (I-Vt.) on Tuesday challenged Novo Nordisk's CEO to lower the cost of semaglutide (Ozempic, Wegovy) during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing.
Sanders, the chair of the...